Risk Adjustment Using Automated Ambulatory Pharmacy Data

Center for Health Studies, Group Health Cooperative, Seattle, Washington 98101, USA.
Medical Care (Impact Factor: 2.94). 02/2003; 41(1):84-99. DOI: 10.1097/01.MLR.0000039830.19812.29
Source: PubMed

ABSTRACT Develop and estimate the RxRisk model, a risk assessment instrument that uses automated ambulatory pharmacy data to identify chronic conditions and predict future health care cost. The RxRisk model's performance in predicting cost is compared with a demographic-only model, the Ambulatory Clinical Groups (ACG), and Hierarchical Coexisting Conditions (HCC) ICD-9-CM diagnosis-based risk assessment instruments. Each model's power to forecast health care resource use is assessed.
Health services utilization and cost data for approximately 1.5 million individuals enrolled in five mixed-model Health Maintenance Organizations (HMOs) from different regions in the United States.
Retrospective cohort study using automated managed care data. SUBJECTS All persons enrolled during 1995 and 1996 in Group Health Cooperative of Puget Sound, HealthPartners of Minnesota and the Colorado, Ohio and Northeast Regions of Kaiser-Permanente. MEASURES RxRisk, an algorithm that classifies prescription drug fills into chronic disease classes for adults and children.
HCCs produce the most accurate forecasts of total costs than either RxRisk or ACGs but RxRisk performs similarly to ACGs. Using the R(2) criteria HCCs explain 15.4% of the prospective variance in cost, whereas RxRisk explains 8.7% and ACGs explain 10.2%. However, for key segments of the cost distribution the differences in forecasting power among HCCs, RxRisk, and ACGs are less obvious, with all three models generating similar predictions for the middle 60% of the cost distribution.
HCCs produce more accurate forecasts of total cost, but the pharmacy-based RxRisk is an alternative risk assessment instrument to several diagnostic based models and depending on the nature of the application may be a more appropriate option for medical risk analysis.

Download full-text


Available from: Paul Fishman, Jul 04, 2015
1 Follower
  • [Show abstract] [Hide abstract]
    ABSTRACT: The objective of the study is to obtain the cost's relative average weights of the assistance with the retrospective application of the Adjusted Clinical Groups (ACG's) in four teams of Primary Care with an attended population in the habitual clinical practice situation. Descriptive study of retrospective character. It was included in the study all attended patients by four teams of Primary Care during year 2003. The main measures were: universal variables (age and gender), dependents (visits and costs) and casuistic and co morbidity. The model of cost per each patient was established differencing the fix costs and the variable ones. Was effected a multiple lineal regression analysis for the prediction of models. The relative cost of each ACG was obtained dividing the average cost of each category among the average cost of each population of reference. The total number of the studied patients was 62,311 (intensity of use: 76.7%), with an average 4.8 +/- 3.2 episodes and 7.8 +/- 7.5 visits/patient/year. The distribution of costs was 24,135,236.41 euro, 28.9% for fix. The total unitary cost per visit/year was 49.62 +/- 24.71 euro and the average of the total cost per patient/year 387.34 +/- 145.87 euro (relative weights of reference). The explicative power of the classification of ACG was 50.1% in visits and 54.9% for total costs. The ACG are an acceptable system of classification of patients in situation of habitual clinic practice. In case results were confirmed will make possible an improvement in the practice application of ACG as a possible tool for the clinical management in Primary Care centers.
    Gaceta Sanitaria 20(2):132-41.
  • Source
    [Show abstract] [Hide abstract]
    ABSTRACT: We sought to determine the association between timely receipt of diabetes-related preventive services and the longitudinal pattern of outpatient service use as characterized by a novel taxonomy that prioritized visits based on the Oregon State Prioritized Health Services List. We performed a cross-sectional analysis of mail survey and automated health care data for a population-based sample of patients with diabetes enrolled in a health maintenance organization in Washington State (N = 4,463). Outcomes included American Diabetes Association-recommended preventive services, including regular hemoglobin A1C (HbA1C) monitoring, retinal examination, and microalbuminuria screening. Patients with fewer than 8 visits during the 2-year study period were considered infrequent users, while patients with 8 or more visits were classified as lower-priority users if most visits were for conditions of relatively low rank on the Oregon list and as higher-priority users otherwise. After adjustment for social, demographic, and clinical factors, and depression, infrequent users had significantly reduced odds of receiving at least 1 HbA1C test (odds ratio [OR] = 0.35, 95% confidence interval [CI], 0.24-0.51), retinal examination (OR = 0.74, 95% CI, 0.63-0.86), and microalbuminuria screening (OR = 0.75, 95% CI, 0.58-0.96) relative to higher-priority users during the previous year. Lower-priority users also had relatively reduced odds of receiving at least 1 HbA(1C) test (OR = 0.59, 95% CI, 0.35-1.01), retinal examination (OR = 0.68, 95% CI, 0.56-0.84), and microalbuminuria screening (OR = 0.79, 95% CI, 0.57-1.09) despite attending a similar mean number of total visits as higher-priority users. Patients who attend relatively few outpatient visits or who attend more frequent visits for predominantly lower-priority conditions are more likely to receive substandard preventive care for diabetes.
    The Annals of Family Medicine 01/2006; 4(1):32-9. DOI:10.1370/afm.421
  • Source
    [Show abstract] [Hide abstract]
    ABSTRACT: Adaptation of the categories Johns-Hopkins ACG Case-Mix System in Primary Healthcare: a longitudinal, retrospective claim database studyAntonio Sicras-Mainar1§, Soledad Velasco-Velasco1*, Ruth Navarro-Artieda2*, Oleguer Plana-Ripoll3*, Alba Aguado Jodar4*, Eduardo Hermosilla-Pérez3*, Bonaventura Bolibar-Ribas3*, Amador Ruíz Torrejón5*, Alejandra Prados-Torres6*, Concepción Violan-Fors3*.1Directorate of Planning. Badalona Serveis Assistencials SA, Badalona, Spain.2Medical Documentation. Hospital Universitari Germans Trias i Pujol, Badalona, Spain3Jordi Gol i Gurina Primary Health Care Research Institute. IDIAP, Barcelona, Spain4Directorate of Primary Care, Integral Health Consortium, Barcelona, Spain5Primary Health Care Management of Mallorca, Palma de Mallorca, Spain6Health Sciences Institute of Aragon, Zaragoza, Spain* These authors contributed equally to this work. The manuscript was approved form all authors.§ Corresponding authorEmail addresses:Antonio Sicras-Mainar: asicras@bsa.catSoledad Velasco-Velasco: svelasco@bsa.catRuth Navarro-Artieda: rnavarro.germanstrias@gencat.catOleguer Plana-Ripoll: oplana@idiapjgol.orgAlba Aguado-Jodar: alba.aguado@sanitatintegral.orgEduardo Hermosilla-Pérez: ehermosilla@idiapjgol.infoBonaventura Bolibar-Ribas: bbolibar@idiapjgol.orgAmador Ruíz-Torrejón: aruiz@ibsalut.caib.esAlejandra Prados-Torres: sprados.iacs@aragon.esConcepción Violan-Fors: cviolan@idiapjgol.orgIn representation ACG Study Group:Catalonia (Milagrosa Blanca-Tamayo, Esperanza Escribano-Herranz, Ferran Flor-Serra, Josep Ramón Llopart-López, Daniel Rodríguez-López, Encarna Sánchez-Fontcuberta, Josep Maria Vilaseca-Llobet), Mallorca (José Estelrich-Bennasar, Vicente Juan Verger, María Antònia Mir-Pons, María Vega Martín-Martín, Juan Antonio Pérez-Artigues) and Aragon (José María Abad-Díez, María Mercedes Aza Pascual-Salcedo, Daniel Bordonaba-Bosque, Amaya Calderón-Larrañaga, Francisca González-Rubio, Anselmo López-Cabañas, Jesús Magdalena-Belio, Beatriz Poblador-Plou, Antonio Poncel-Falcó).